Biopsy, Fine-Needle
8
0
0
5
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 37/100
0.0%
0 terminated out of 8 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
40%
2 of 5 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 5 completed trials
Clinical Trials (8)
Diagnostic Efficacy of EUS-FNA/B Versus ERCP With or Without POCS-TB in Patients With Suspected Hilar Cholangiocarcinoma
iNod™ Ultrasound-Guided Needle Biopsy System Study
iNod System Human Feasibility Assessment
EUS-FNB for Solid Pancreatic Lesions: Side-fenestrated Vs Fork-tip Needle
EUS-FNB With ROSE Vs. EUS-FNB Without ROSE
Impact of Suction in the EUS-guided Fine Needle Biopsy of Solid Pancreatic Lesions
Comparison of DNA Ploidy and Conventional Cytology
EUS-guided Fine Needle Aspiration (FNA) With and Without the Use of a Stylet